Treatment of Alopecia with Botulinum Toxin (Botox)

Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin (Botox)

Purpose

The purpose of this study is to examine prospectively the safety and efficacy of Botulinum Toxin A (Botox) injections in the treatment of patients with alopecia areata of the scalp.

Eligibility

Ages Eligible for Study: 19 Years – 65 Years, Genders Eligible for Study: Both

Inclusion Criteria:

  • Patients with long standing alopecia areata, patches must be at least 4 cm in diameter

Exclusion Criteria:

  • Intake of drugs that interfere with Botulinum toxin A such as gentamicin, tobramycin, clindamycin and lincomycin; medications used to treat heart rhythm problems, such as quinidine; and medications used to treat other conditions, such as myasthenia gravis, ALS or Alzheimer’s disease.
  • Neuromuscular disorders such as Myasthenia gravis and Lambert-Eaton-Syndrome.
  • Treatment with another investigational drug within 4 weeks prior to anticipated first treatment.
  • Females who are pregnant, planning to become pregnant during the study period, or breastfeeding.

(This study was confirmed as not yet recruiting as of December of 2006. But the study was set to begin recruiting in January of 2007, so if you are interested you should look into contacting the study investigators using the contact info supplied in the link.)

Speak Your Mind